A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: Results from the ADAMO trial

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages 1335-1342

  Langdahl, Bente L ^a   Teglbjærg, Christence Stubbe ^b   Ho, Pei Ran ^c   Chapurlat, Roland ^d   Czerwinski, Edward ^e   Kendler, David L ^f   Reginster, Jean Yves ^g   Kivitz, Alan ^h   Lewiecki, E Michael ⁱ   Miller, Paul D ^j   Bolognese, Michael A ^k   McClung, Michael R ^l   Bone, Henry G ^m   Ljunggren, Östen ⁿ   Abrahamsen, Bo ^o   Gruntmanis, Ugis ^p   Yang, Yu Ching ^c   Wagman, Rachel B ^c   Mirza, Faisal ^c   Siddhanti, Suresh ^c   Orwoll, Eric ^q   more..

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c AMGEN INC   (United States)

^d UNIVERSITÉ DE LYON   (France)

^e Krakow Medical Center   (Poland)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h Altoona Center for Clinical Research   (United States)

ⁱ NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

^j Health Sciences Center and Colorado Center for Bone Research   (United States)

^k Bethesda Health Research Center   (United States)

^l OREGON OSTEOPOROSIS CENTER   (United States)

^m Michigan Bone and Mineral Clinic   (United States)

ⁿ UPPSALA UNIVERSITY   (Sweden)

^o UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^p UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^q OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; DENOSUMAB; PLACEBO; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; MONOCLONAL ANTIBODY;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLADDER CANCER; BONE DENSITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; FEMUR FRACTURE; HEART DISEASE; HUMAN; HYPERSENSITIVITY; HYPOCALCEMIA; INFECTION; JAW OSTEONECROSIS; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; MULTICENTER STUDY; OSTEOLYSIS; OSTEOPOROSIS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; TREATMENT OUTCOME; VASCULAR DISEASE; VERY ELDERLY; CLINICAL TRIAL; DRUG EFFECTS; FEMUR NECK; FRACTURES, BONE; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; RADIOGRAPHY; RADIUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMUR NECK; FRACTURES, BONE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; RADIUS; TREATMENT OUTCOME;

EID: 84927602910     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4079     Document Type: Article

References (10)

1. National Osteoporosis Foundation. Just for men. http://www.nof.org/articles/236. Accessed June 18, 2013.
2. Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev. 2008;29:441-464.
3. Haentjens P, Magaziner J, Colón-Emeric CS, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152:380-390.
4. Gallagher AM, Rietbrock S, Olson M, van Staa TP. Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res. 2008;23:1569-1575.
5. Novartis Pharmaceuticals. Reclast (zoledronic acid) [injection prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals, 2014.
6. Li Y, Xuan M, Wang B, et al. Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China. Chin Med J (Engl). 2013;126:457-463.
7. Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756-765.
8. Orwoll E, Teglbjærg CS, Langdahl BL, et al. Arandomized, placebocontrolled study of the effects of denosumab for the treatment ofmen with low bone mineral density. J Clin Endocrinol Metab. 2012;97:3161-3169.
9. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-1148.
10. Smith MR, Egerdie B, Hernández Toriz N, et al. Denosumab in men receiving and rogen-deprivation therapy for prostate cancer. NEngl J Med. 2009;361:745-755.